Pyridoxal hydrochloride

CAS No. 65-22-5

Pyridoxal hydrochloride ( —— )

Catalog No. M19654 CAS No. 65-22-5

The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids neurotransmitters (serotonin norepinephrine) sphingolipids aminolevulinic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pyridoxal hydrochloride
  • Note
    Research use only not for human use.
  • Brief Description
    The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids neurotransmitters (serotonin norepinephrine) sphingolipids aminolevulinic acid.
  • Description
    The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids neurotransmitters (serotonin norepinephrine) sphingolipids aminolevulinic acid.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65-22-5
  • Formula Weight
    203.62
  • Molecular Formula
    C8H10ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    Cl.Cc1ncc(CO)c(C=O)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rajamohan F Nelms L Joslin D L et al. cDNA cloning expression purification distribution and characterization of biologically active canine alanine aminotransferase-1.[J]. Protein Expr Purif 2006 48(1):81-89.
molnova catalog
related products
  • Protocatechuic acid ...

    The herbs of Gastrodia elata BL.

  • EVP-6124 hydrochlori...

    EVP-6124 hydrochloride is a new-type partial agonist of α7 neuronal nicotinic acetylcholine receptors (nAChRs).

  • Marmin

    Marmin have anti-ulcer effects, which are ascribed primarily to the maintenance of the mucosal barrier integrity and inhibition of gastric motor activity and secondarily due to the prevention of the effects of endogenous acetylcholine and histamine.